Your browser doesn't support javascript.
loading
NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma.
Ueda, Shugo; Miyahara, Yoshihiro; Nagata, Yasuhiro; Sato, Eiichi; Shiraishi, Taizo; Harada, Naozumi; Ikeda, Hiroaki; Shiku, Hiroshi; Kageyama, Shinichi.
Afiliação
  • Ueda S; Department of Gastroenterological Surgery and Oncology, Kitano Hospital, Kita-ku, Osaka 530-8480, Japan.
  • Miyahara Y; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
  • Nagata Y; Center for Comprehensive Community Care Education, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan.
  • Sato E; Department of Pathology, Institute of Medical Science, Tokyo Medical University, Shinjuku-ku, Tokyo 160-0023, Japan.
  • Shiraishi T; Department of Oncologic Pathology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
  • Harada N; United Immunity, Co., Ltd., Tsu, Mie 514-8507, Japan.
  • Ikeda H; Department of Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan.
  • Shiku H; Departments of Immuno-Gene Therapy and Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
  • Kageyama S; Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
Oncotarget ; 9(89): 35997-36011, 2018 Nov 13.
Article em En | MEDLINE | ID: mdl-30542513

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article